SCHEMBL2594095

SCHEMBL2594095

CCOC(=O)c1c(C(F)(F)F)n[nH]c1C(C)(C)CN

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.49
MAPT P10636 2/20 0.49
KMT2A Q03164 2/20 0.49
POLB P06746 1/20 0.49
PDE4D Q08499 1/20 0.43
ALDH1A1 P00352 6/20 0.36
HPGD P15428 5/20 0.36
SMN1; SMN2 Q16637 4/20 0.36
IDO1 P14902 1/20 0.36
GAA P10253 1/20 0.36
HTT P42858 2/20 0.35
MAPK10 P53779 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
PLAT P00750 1/20 0.34
MEN1 O00255 1/20 0.34
LMNA P02545 1/20 0.34
PKM P14618 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
FHIT P49789 1/20 0.33
HSD17B10 Q99714 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20471481 0.79 KDM4E (0.74) KDM4EMAPTKMT2APOLBPDE4D
SCHEMBL17777909 0.76 KDM4E (0.55) KDM4EMAPTKMT2APOLBPDE4D
SCHEMBL4650523 0.76 KDM4E (0.55) KDM4EMAPTKMT2APOLBPDE4D
SCHEMBL4650539 0.74 KDM4E (0.52) KDM4EMAPTKMT2APOLBPDE4D
SCHEMBL4650693 0.74 KDM4E (0.52) KDM4EMAPTKMT2APOLBPDE4D
SCHEMBL4125363 0.73 SMN1; SMN2 (0.50) KDM4EMAPTKMT2APOLBPDE4D
SCHEMBL7470961 0.73 PDE4D (0.65) KDM4EMAPTKMT2APOLBPDE4D
SCHEMBL20471495 0.72 KDM4E (0.50) KDM4EMAPTKMT2APOLBPDE4D
SCHEMBL3848316 0.71 KDM4E (0.52) KDM4EMAPTKMT2APOLBPDE4D
SCHEMBL4650633 0.71 KDM4E (0.49) KDM4EMAPTKMT2APOLBPDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2566866-A1 4 SUBSTITUTED PYRAZOLOPYRIMIDINES USEFUL AS PKC-THETA INHIBITORS Vertex Pharmaceuticals Incorporated (US) 2013-03-13 EP disclosed
WO-2011139273-A1 4 SUBSTITUTED PYRAZOLOPYRIMIDINES USEFUL AS PKC-THETA INHIBITORS VERTEX PHARMACEUTICALS INCORPORATED (US) 2011-11-10 WO disclosed